2-naphthylamine has been researched along with Disease Models, Animal in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alam, HB; Chen, E; Chong, W; Deng, Q; Li, Y; Liang, Y; Liu, B; Mobley, J; Pan, B; Tewari, M; Wang, T; Wang, Y | 1 |
Alam, HB; Chen, E; Deng, Q; Duan, X; Li, Y; Liang, Y; Liu, B; Pan, B; Tian, Y; Wang, Y; Williams, AM; Zhang, J | 1 |
Cvačka, J; Maletínská, L; Popelová, A; Pražienková, V; Strnad, Š; Sýkora, D; Vrkoslav, V | 1 |
Diao, XW; Fa, HB; Li, S; Yin, W; Zhang, D; Zhou, JT | 1 |
Booth, RG; Canal, CE; Felsing, DE; Liu, Y; Perry, CK; Vemula, R; Wood, JT; Zhu, W | 1 |
Costall, B; Naylor, RJ; Owen, RT | 1 |
6 other study(ies) available for 2-naphthylamine and Disease Models, Animal
Article | Year |
---|---|
CitH3: a reliable blood biomarker for diagnosis and treatment of endotoxic shock.
Topics: 2-Naphthylamine; Animals; Arginine; Biomarkers; Citrullination; Diagnostic Tests, Routine; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Extracellular Traps; Histones; Immunologic Factors; Mice; Protein Processing, Post-Translational; Sensitivity and Specificity; Shock, Septic; Time Factors; Treatment Outcome | 2017 |
Inhibition of peptidylarginine deiminase alleviates LPS-induced pulmonary dysfunction and improves survival in a mouse model of lethal endotoxemia.
Topics: 2-Naphthylamine; Acute Lung Injury; Animals; Arginine; Citrullination; Disease Models, Animal; Endothelial Cells; Endothelium, Vascular; Endotoxemia; Extracellular Traps; Histones; Human Umbilical Vein Endothelial Cells; Humans; Lipopolysaccharides; Lung; Mice; Mice, Inbred C57BL; Microvessels; Neutrophils; Permeability; Protein-Arginine Deiminases; Treatment Outcome | 2018 |
The use of 1,5-diaminonaphthalene for matrix-assisted laser desorption/ionization mass spectrometry imaging of brain in neurodegenerative disorders.
Topics: 2-Naphthylamine; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Disease Models, Animal; Gangliosides; Glycerophospholipids; Male; Mice, Inbred C57BL; Reproducibility of Results; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; tau Proteins | 2019 |
The detection of β-amyloid plaques in an Alzheimer's disease rat model with DDNP-SPIO.
Topics: 2-Naphthylamine; Acrylonitrile; Alzheimer Disease; Animals; Case-Control Studies; Coloring Agents; Congo Red; Contrast Media; Disease Models, Animal; Ferrocyanides; Hippocampus; Magnetic Resonance Imaging; Magnetite Nanoparticles; Plaque, Amyloid; Rats; Spectrometry, Fluorescence | 2015 |
An Orally Active Phenylaminotetralin-Chemotype Serotonin 5-HT7 and 5-HT1A Receptor Partial Agonist that Corrects Motor Stereotypy in Mouse Models.
Topics: 2-Naphthylamine; Administration, Oral; Amphetamines; Animals; Blood-Brain Barrier; Brain; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Locomotion; Male; Mice, Inbred C57BL; Molecular Structure; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin; Serotonin Receptor Agonists; Social Behavior; Stereotyped Behavior; Tetrahydronaphthalenes | 2015 |
Gabaminergic and serotonergic modulation of the antidyskinetic effects of tiapride and oxiperomide in the model using 2-(N,N-dipropyl)animo-5,6-dihydroxytetralin.
Topics: 2-Naphthylamine; Aminobutyrates; Animals; Behavior, Animal; Benzamides; Benzimidazoles; Disease Models, Animal; Female; gamma-Aminobutyric Acid; Guinea Pigs; Injections, Intraventricular; Male; Movement Disorders; Naphthalenes; Quipazine; Serotonin; Tetrahydronaphthalenes; Time Factors; Tranquilizing Agents; Valproic Acid | 1978 |